[An innovative protocol, cyclic hormone-chemotherapy in the treatment of high-risk localized endometrial cancer].
Audet-Lapointe
P
P
Service d'Oncologie-Gynécologique, Hôpital Notre-Dame, Montreal, Quebec, Canada.
Ayoub
J
J
Methot
Y
Y
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000628:therapy; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002985:Clinical Protocols; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D011374:Progesterone / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000628:therapy
D013629:Tamoxifen; D011374:Progesterone
Un protocole innovateur, l'hormono-chimiothérapie cyclique dans le traitement du cancer de l'endomètre localise et à haut risque.